Stock Fundamentals

Company Information

Company Name
Kyverna Therapeutics, Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US5019761049
CIK: 0001994702
CUSIP: 501976104
Currency: USD
Full Time Employees: 129
Phone: 510 925 2492
Fiscal Year End: December
IPO Date: Feb 08, 2024
Description:

Kyverna Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and autoimmune diseases. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.

Address:

5980 Horton Street, EmeryVille, CA, United States, 94608

Directors & Officers

Name Title Year Born
Ms. Christi L. Shaw Executive Chairperson 1967
Mr. Warner Biddle CEO & Director 1967
Dr. Naji H. Gehchan M.B.A., M.D. Chief Medical & Development Officer 1982
Dr. Marc Grasso M.D. Strategic Advisor 1973
Mr. Gregory Martini Chief Financial Officer 1989
Dr. Tom Van Blarcom Ph.D. Senior VP & Head of Research NA
Mr. Mayo Pujols Chief Technology Officer 1970
Ms. Jessica Serra Head of Investor Relations NA
Mr. Ritesh Srivastava Chief Legal & Compliance Officer NA
Ms. Cara Bauer Ph.D. Chief Human Resources Officer NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Dec 18, 2025 Beth C Seidenberg N/A Purchase 133.33K $7.50 $1,000.00K
Dec 18, 2025 Biopartners Opportuni Westlake N/A Purchase 133.33K $7.50 $1,000.00K
Dec 15, 2025 Karen Marie Walker N/A Sale 24.00K $12.20 $292.78K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
GordonMD Global Investments LP 4.24M Mar 31, 2026 7.01% $25.51 -3.35%
Bain Capital Life Sciences Investors, LLC 3.11M Mar 31, 2026 5.14% $2.42 0.00%
AIGH Capital Management, LLC 2.00M Mar 31, 2026 3.30% $2.35 33.33%
Deerfield Management Co 2.00M Mar 31, 2026 3.30% $0.20 0.00%
Vanguard Capital Management, LLC 1.78M Mar 31, 2026 2.95% $0.00 0.00%
Vanguard Group Inc 1.78M Dec 31, 2025 2.94% $0.00 34.68%
T. Rowe Price Associates, Inc. 1.56M Mar 31, 2026 2.57% $0.00 -11.76%
Balyasny Asset Management LLC 1.13M Mar 31, 2026 1.86% $0.01 14.73%
Millennium Management LLC 1.01M Mar 31, 2026 1.66% $0.00 69.46%
INSIGHT HOLDINGS GROUP, LLC 989.05K Mar 31, 2026 1.63% $0.60 0.00%
Morgan Stanley - Brokerage Accounts 977.29K Mar 31, 2026 1.61% $0.00 -2.51%
BlackRock Inc 877.08K Mar 31, 2026 1.45% $0.00 61.07%
Woodline Partners LP 845.33K Mar 31, 2026 1.40% $0.03 0.02%
D. E. Shaw & Co LP 721.58K Mar 31, 2026 1.19% $0.00 39.16%
Propel Bio Management LLC 666.67K Dec 31, 2025 1.10% $5.35 0.00%
MBB PUBLIC MARKETS I LLC 614.48K Mar 31, 2026 1.02% $0.63 0.00%
Marshall Wace Asset Management Ltd 605.51K Mar 31, 2026 1.00% $0.01 346.54%
Susquehanna International Group, LLP 577.60K Mar 31, 2026 0.95% $0.00 141.85%
Adage Capital Partners Gp LLC 500.00K Mar 31, 2026 0.83% $0.01 -70.00%
UBS Group AG 449.75K Mar 31, 2026 0.74% $0.00 122.44%

Shares Statistics

Shares Outstanding: 60.80M
Shares Float: 35.55M
% Insiders: 709.90%
% Institutions: 7,442.90%
Short % Float: 13.99%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 1.35M 2.23% ▲ 0.00% Apr 30, 2026
2 MEDICAL BioHealth EUR Acc 1.31M 2.17% ▲ 27.26% Apr 30, 2026
3 T. Rowe Price Health Sciences 856.80K 1.42% ▼ 24.98% Apr 30, 2026
4 Vanguard Institutional Extnd Mkt Idx Tr 398.85K 0.66% ▲ 0.58% Apr 30, 2026
5 iShares Biotechnology ETF 245.92K 0.41% ▲ 1.96% May 29, 2026
6 Fidelity Extended Market Index 190.65K 0.32% ▼ 0.36% Apr 30, 2026
7 Schwab US Small-Cap ETF™ 167.96K 0.28% ▲ 0.06% May 30, 2026
8 Invesco Dorsey Wright SmallCap Momt ETF 166.18K 0.27% ▼ 0.28% May 29, 2026
9 apo Medical Opportunities R 150.00K 0.25% ▲ 0.00% Apr 30, 2026
10 Simplify Propel Opportunities ETF 130.53K 0.22% ▲ 0.00% May 29, 2026

Valuation Metrics

Enterprise Value: $393.71M
Trailing P/E: 0.00
Forward P/E: 0.00

Financial Highlights

Market Cap: $515.85M
EBITDA: $-162.14M
Book Value: $3.23
Earnings/Share: $-2.83
Profit Margin: 0.00%
Operating Margin: 0.00%
ROA (TTM): -39.55%
ROE (TTM): -74.55%
Revenue (TTM): $0.00
Revenue/Share (TTM): $0.00
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 0.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 7.75x 0.12x 0.21x -347.29x -0.18x
2024-12-31 8.61x 0.01x 0.12x -1,004.25x -0.03x
2023-12-31 3.05x 0.06x 0.35x -333.72x -0.05x
2022-12-31 4.45x 0.05x 0.30x -452.06x -0.08x
2021-12-31 4.84x -0.02x 1.54x -8,782.00x -0.03x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about KYTX.US!